(2R,3R,4S,5S,6R)-2-(((2R,3S,4S,5R,6S)-6-(((3R,6R)-6-((3S,8S,9R,10R,11R,13R,14S,17R)-3,11-Dihydroxy-4,4,9,13,14-pentamethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxy-2-methylheptan-3-yl)oxy)-3,4-dihydroxy-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)methoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

Catalog No. :
ACHYPW523
CAS No. :
88901-42-2
Molecular Formula :
C48H82O19
Molecular Weight :
963.16

IUPAC Name:(2R,3R,4S,5S,6R)-2-(((2R,3S,4S,5R,6S)-6-(((3R,6R)-6-((3S,8S,9R,10R,11R,13R,14S,17R)-3,11-dihydroxy-4,4,9,13,14-pentamethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxy-2-methylheptan-3-yl)oxy)-3,4-dihydroxy-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)methoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

(2R,3R,4S,5S,6R)-2-(((2R,3S,4S,5R,6S)-6-(((3R,6R)-6-((3S,8S,9R,10R,11R,13R,14S,17R)-3,11-Dihydroxy-4,4,9,13,14-pentamethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxy-2-methylheptan-3-yl)oxy)-3,4-dihydroxy-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)methoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg95%$148.00Login to see priceInquiryInquiry
10mg95%$243.00Login to see priceInquiryInquiry
25mg95%$607.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3R,4S,5S,6R)-2-(((2R,3S,4S,5R,6S)-6-(((3R,6R)-6-((3S,8S,9R,10R,11R,13R,14S,17R)-3,11-Dihydroxy-4,4,9,13,14-pentamethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxy-2-methylheptan-3-yl)oxy)-3,4-dihydroxy-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)methoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
IUPAC Name(2R,3R,4S,5S,6R)-2-(((2R,3S,4S,5R,6S)-6-(((3R,6R)-6-((3S,8S,9R,10R,11R,13R,14S,17R)-3,11-dihydroxy-4,4,9,13,14-pentamethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxy-2-methylheptan-3-yl)oxy)-3,4-dihydroxy-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)methoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
MDL No.-
Molecular FormulaC48H82O19
Molecular Weight963.16
SMILESC[C@]12[C@]3([C@](C)([C@]4(C(=CC3)C(C)(C)[C@@H](O)CC4)[H])[C@H](O)C[C@]1(C)[C@@]([C@@H](CC[C@@H](O[C@H]5[C@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)O5)[C@](C)(C)O)C)(CC2)[H])[H]
InChI KeyDDDXYRAMQRKPDO-GOILQDHQSA-N
Synonym11-O-Mogroside IIIA1 | (2R,3R,4S,5S,6R)-2-(((2R,3S,4S,5R,6S)-6-(((3R,6R)-6-((3S,8S,9R,10R,11R,13R,14S,17R)-3,11-Dihydroxy-4,4,9,13,14-pentamethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxy-2-methylhepta
CAS No.88901-42-2
PubChem CID102594497

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACHYPW523 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHYPW523 route product structure diagram
    ACHYPW52388901-42-2
Inquiry

2. ACHYPW523 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHYPW523 route product structure diagram
    ACHYPW52388901-42-2
Inquiry

Comments (0)